Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q4 FY26 results · Jan–Mar 2026

Advanced Enzyme Technologies reported revenue from operations of ₹203.37 crore (up 21.6% from Q4 FY25) and net profit of ₹45.25 crore (up 69.3% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations203.37167.18+21.6%171.95+18.3%
Other income7.238.74−17.3%8.47−14.7%
Total income210.59175.92+19.7%180.42+16.7%
Profit before tax59.8043.46+37.6%58.29+2.6%
Net profit for the period45.2526.73+69.3%43.18+4.8%
Attributable to shareholders of the company42.9626.48+62.2%42.50+1.1%
EPS, basic (₹)3.842.37+62.0%3.80+1.1%
Net margin (%)22.316.025.1
Standalone · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations116.4187.21+33.5%95.58+21.8%
Other income5.164.53+14.0%1.29+299.0%
Total income121.5791.74+32.5%96.88+25.5%
Profit before tax28.8415.51+86.0%17.82+61.9%
Net profit for the period22.3011.05+101.7%13.25+68.3%
EPS, basic (₹)1.990.99+101.0%1.18+68.6%
Net margin (%)19.212.713.9
Consolidated
Filed with BSE
09 May 2026, 15:48 IST
Board meeting
09 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
09 May 2026, 15:48 IST
Board meeting
09 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE